CYTEIR THERAPEUTICS INC (CYT)

US23284P1030 - Common Stock

3.02  -0.07 (-2.27%)

After market: 3.1 +0.08 (+2.65%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2023-9-30)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
129.20M147.10M189.70M10.90M29.00M
Receivables
0.00N/A0.00100.00K200.00K
Other Current Assets
1.40M2.10M3.30M1.10M1.30M
Total Current Assets
130.60M149.20M193.10M12.10M30.40M
 
Non-Current Assets
PPE Net
100.00K3.80M2.10M1.30M800.00K
Other Non-Current Assets
300.00K300.00K300.00K300.00K100.00K
Total Non-Current Assets
400.00K4.00M2.30M1.60M1.00M
 
TOTAL ASSETS
131.00M153.20M195.40M13.70M31.40M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
5.50M4.20M5.70M1.40M1.40M
Accounts Payable
500.00K1.10M1.80M1.70M600.00K
Total Current Liabilities
6.00M5.30M7.50M3.10M2.00M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
0.001.60M600.00K1.20M300.00K
Total Non-Current Liabilities
0.001.60M600.00K1.30M300.00K
 
TOTAL LIABILITIES
6.00M6.90M8.10M4.40M2.30M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-162.50M-138.10M-92.10M-49.90M-29.10M
Additional Paid In Capital
287.50M284.40M279.30M1.90M800.00K
Common Shares
0.000.000.0057.40M57.40M
Shares Outstanding
36.10M35.50M35.20M34.50M34.50M
Tangible Book Value per Share
3.464.125.32-1.39-0.82
Total Shareholders' Equity
125.00M146.30M187.30M9.40M29.10M
 
TOTAL LIABILITIES AND EQUITY
131.00M153.20M195.40M13.70M31.40M
 
Statistics
Current Ratio
21.7728.1525.753.9015.20
Return On Assets (ROA)
-25.35%-30.07%-21.56%-151.97%-47.90%
Return On Equity (ROE)
-26.57%-31.48%-22.49%-221.49%-51.68%

All data in USD

Charts